GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytokinetics Inc (FRA:KK3A) » Definitions » Cyclically Adjusted FCF per Share

Cytokinetics (FRA:KK3A) Cyclically Adjusted FCF per Share : €-1.78 (As of Mar. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Cytokinetics Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Cytokinetics's adjusted free cash flow per share for the three months ended in Mar. 2024 was €-1.169. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €-1.78 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -10.10% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 0.20% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 12.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Cytokinetics was 34.10% per year. The lowest was -10.10% per year. And the median was 14.30% per year.

As of today (2024-05-26), Cytokinetics's current stock price is €44.40. Cytokinetics's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was €-1.78. Cytokinetics's Cyclically Adjusted Price-to-FCF of today is .


Cytokinetics Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Cytokinetics's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytokinetics Cyclically Adjusted FCF per Share Chart

Cytokinetics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.57 -1.11 -1.10 -1.28 -1.63

Cytokinetics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.21 -1.53 -1.71 -1.63 -1.78

Competitive Comparison of Cytokinetics's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, Cytokinetics's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cytokinetics's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cytokinetics's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Cytokinetics's Cyclically Adjusted Price-to-FCF falls into.



Cytokinetics Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cytokinetics's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-1.169/131.7762*131.7762
=-1.169

Current CPI (Mar. 2024) = 131.7762.

Cytokinetics Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -0.198 100.560 -0.259
201409 -0.204 100.428 -0.268
201412 -0.185 99.070 -0.246
201503 0.818 99.621 1.082
201506 -0.215 100.684 -0.281
201509 -0.239 100.392 -0.314
201512 -0.238 99.792 -0.314
201603 -0.407 100.470 -0.534
201606 -0.252 101.688 -0.327
201609 -0.256 101.861 -0.331
201612 1.677 101.863 2.169
201703 -0.502 102.862 -0.643
201706 -0.582 103.349 -0.742
201709 -0.405 104.136 -0.512
201712 -0.389 104.011 -0.493
201803 -0.451 105.290 -0.564
201806 -0.424 106.317 -0.526
201809 -0.511 106.507 -0.632
201812 -0.201 105.998 -0.250
201903 -0.439 107.251 -0.539
201906 -0.380 108.070 -0.463
201909 -0.329 108.329 -0.400
201912 -0.310 108.420 -0.377
202003 -0.476 108.902 -0.576
202006 -0.422 108.767 -0.511
202009 0.146 109.815 0.175
202012 0.529 109.897 0.634
202103 -0.426 111.754 -0.502
202106 -0.443 114.631 -0.509
202109 -0.576 115.734 -0.656
202112 -0.657 117.630 -0.736
202203 -0.296 121.301 -0.322
202206 -1.008 125.017 -1.063
202209 -0.974 125.227 -1.025
202212 -1.011 125.222 -1.064
202303 -1.204 127.348 -1.246
202306 -1.181 128.729 -1.209
202309 -0.940 129.860 -0.954
202312 -0.686 129.419 -0.698
202403 -1.169 131.776 -1.169

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Cytokinetics  (FRA:KK3A) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Cytokinetics Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Cytokinetics's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Cytokinetics (FRA:KK3A) Business Description

Industry
Traded in Other Exchanges
Address
350 Oyster Point Boulevard, South San Francisco, CA, USA, 94080
Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Cytokinetics (FRA:KK3A) Headlines

No Headlines